Acute tendon rupture is a common tendinopathy often associated with disordered healing. Tendon [3, 4] . The activation of PC is augmented by its specific receptor, endothelial protein C receptor (EPCR) [3] [4] [5] . APC plays a key role in the regulation of blood coagulation and also has significant anti-inflammatory properties associated with inhibition of proinflammatory cytokines and a reduction of leucocyte recruitment [6] [7] [8] [9] [10] 
Introduction
Acute tendon rupture is a common tendinopathy often associated with disordered healing. Tendon injuries account for considerable morbidity and often prove disabling for several months, despite receiving appropriate management [1] . Acute injuries heal by a sequence of overlapping phases involving inflammation, granulation tissue formation and remodelling. Healing can occur by invasion of cells from the surrounding sheath and synovium, although, the cells within the tendon, known as tenocytes, have the full capacity to heal tendon intrinsically [1] . Within the extracellular matrix network, tenoblasts and tenocytes constitute about 90-95% of the cellular elements of tendons [1, 2] . Tenoblasts are immature tendon cells which become elongated over time and transform into tenocytes [2] .
Protein C (PC), a vitamin K-dependent zymogen, is converted to activated protein C (APC) on the cell surface when thrombin binds to thrombomodulin [3, 4] . The activation of PC is augmented by its specific receptor, endothelial protein C receptor (EPCR) [3] [4] [5] . APC plays a key role in the regulation of blood coagulation and also has significant anti-inflammatory properties associated with inhibition of proinflammatory cytokines and a reduction of leucocyte recruitment [6] [7] [8] [9] [10] 
. The effectiveness of APC as an anticoagulant and anti-inflammatory agent is demonstrated by its efficacy as a treatment for
patients with severe sepsis [11] . [13] . In cultured human skin keratinocytes, APC enhances cell proliferation, migration and MMP-2 activity [14] . Recently, a novel fu n ction of APC as a promoter of cutaneous wound healing was identified. In a rat-healing model APC accelerates full thickness wound closure by stimulating re-epithelialization, promoting angiogenesis and preventing inflammation [15] . In pilot human trials APC is proving to be effective in healing chronic leg ulcers [16] . Many of the healing properties of APC are mediated through EPCR [14, 15, 17, 18] , a 46-kD type I transmembrane glycoprotein predominantly expressed by endothelial cells, mainly of larger blood vessels [19] . Recent reports have shown this receptor to be present also on some leucocytes of the innate immune system and keratinocytes [20] [21] [22] [23] .
Activated protein C mediates a healing phenotype in cultured tenocytes
Meilang
APC can activate endothelial matrix metalloproteinase (MMP)-2 [12], a member of the MMP family of zinc-dependent endopeptidases that plays a vital role in the tissue repair process by remodelling the extracellular matrix
Whether 
Zymography
MMP-2 and MMP-9 protein secretion and activation in the culture supernatants were measured using gelatine zymography under non-reducing conditions as described previously [24] .
Statistical analysis
Significance was determined using one-way ANOVA Fig. 1C and D) . APC up-regulated MMP-2 in a dosedependent manner, but had no effect on MMP-9. Zymography confirmed Western blot data and revealed that APC-treatment produced a prominent band representing the activated form of MMP-2, which was also evident in the control cells (Fig. 1D) . (Fig. 3A) . Western blotting confirmed that EPCR protein was present in tenocytes and increased in response to APC treatment (Fig. 3B) (Fig. 4, arrows) . When cells were pre-treated with RCR252, the APC-induced increase in type I collagen was abolished (Fig. 4) . (Fig. 5B) . Similarly, MMP-2 production was reduced by more than 50% after tenocytes were transfected with EPCR siRNA for 48 hrs as detected by zymography (Fig. 5C ). This result was confirmed by Fig. 1 APC stimulates (Fig. 5D) . [14, 25] (Fig. 6) . In contrast, high levels of P-p38 were present under basal conditions and the addition of APC inhibited the activity of this MAP kinase (Fig. 6) (Fig. 6) . 
APC up-regulates type I collagen production by tenocytes

We next investigated whether APC stimulation of cell proliferation and MMP-2 was mediated through EPCR. Specific siRNA was used to inhibit endogenous EPCR expression. The efficacy of EPCR siRNA was detected by Western blot, which showed >90% knockdown of protein expression in cell lysates treated for 24 hrs (Fig. 5B). EPCR siRNA treatment for 72 hrs inhibited cell proliferation by more than 20%, which suggests that either EPCR itself can stimulate proliferation or endogenously derived PC can bind to EPCR and enhance cell growth. This inhibition could not be recovered by addition of the exogenous APC (Fig. 5B), indicating that APC requires EPCR to augment proliferation. This was further confirmed by adding EPCR blocking antibody, RCR252, which abolished the stimulatory effect of APC on cell proliferation
Fig. 3 EPCR expression by cultured human tenocytes. Cells were treated with APC and incubated for 24 hrs. Expression of EPCR was detected by (A) Real time RT-PCR (graph) and PCR product was detected by 2% agarose gel with housekeeping gene GAPDH as an internal control (gel below graph) and (B) Western blot analysis, using cell lysates with ␤-actin used as the loading control and (C) immunohistochemical staining for EPCR in tenocytes (Bar ϭ 20 µm).
Fig. 4 Co-localization of EPCR and type I collagen. Immunofluoresecnt staining for EPCR (red) and type I collagen (green) and nucleus using DAPI (blue) of tenocytes without (Control) or with APC (1 g/ml) in the presence or absence of RCR252 (APC + RCR252) treatment for 24 hrs. When the frames are merged, yellow indicates co-expression. In response to APC, cells expressing high levels of EPCR also expressed high levels of type I collagen (arrows). (Bar ϭ 20 m).
pre-treating APC-stimulated cells with RCR 252 for 24 hrs and detected by Western blot
APC regulates the activation of MAP kinases via EPCR
APC-induced cell proliferation is controlled through the activation of MAP kinases in various cell types
. In this study, the phosphorylated (P) forms of ERK2, p38 and c-Jun were measured by Western blotting in response to APC and EPCR blocking agents. The P-ERK2 level was very low in untreated tenocytes after 24 hrs incubation. The addition of APC for 24 hrs dose-dependently and markedly elevated P-ERK2
. No phosporylated c-jun was detected either in control or following APC treatment (data not shown). Blocking EPCR with RCR252 (10 g/ml) resulted in a reversal of the effects of APC, with a decrease in P-ERK2 and increase in P-p38, whereas the nonblocking antibody, RCR92, had little effect. Treatment of cells with EPCR siRNA resulted in similar effects on the activity of ERK and p38 at 72 hrs
Discussion
Tenocytes and their precursors, tenoblasts, account for up to 95% of the cellular component of tendons [1] . These [15] . In human skin keratinocytes, recombinant APC stimulates proliferation, MMP-2 activity, migration and prevents apoptosis, all vital processes of re-epithelialization [17] . In addition, APC has positive effects on endothelial cells and has potent angiogenic activity, which contributes to its wound healing ability [15, 25] [26] . Type I collagen is by far the most abundant, comprising ~95% of the total collagen content [26] . The dry mass of human tendons is approximately 30% of the total tendon mass, with type I collagen accounting for 65% to 80% of this [2, 27, 28] . Although APC is known to promote cutaneous healing, there are no reports on the effect of APC on collagen in any cell type. The current study is the first to show that APC can stimulate type I collagen protein production. An interesting observation, using immunofluorescence, is that EPCR and type I collagen appear to be co-localized (Fig. 4) APC increased MMP-2 synthesis by tenocytes, but had no effect on MMP-9, which was not expressed by tenocytes (Fig. 1) . APC also stimulated the conversion of MMP-2 to its fully active form, as previously described for endothelial cells [29] . MMPs are important regulators of matrix remodelling and their expression varies during tendon healing. Using a rat flexor tendon laceration model, Oshiro [30] [34] . Since MMP-2 is present throughout the tendon healing process [30] , it is likely that by stimulating and activating MMP-2, APC contributes to tendon healing in vitro both by remodelling matrix and suppressing excessive inflammation.
An important finding from this study is that EPCR is expressed by sheep tenocytes (Fig. 3) . This receptor was first identified on endothelial cells, mainly on larger blood vessels [19] and recently has been found on leucocytes, smooth muscle cells and keratinocytes [17, [20] [21] [22] 35] [15, 17, [20] [21] [22] 35] , but it is unknown whether APC acts through this pathway in tenocytes.
An unexpected finding was that EPCR siRNA, when used alone, inhibited tenocyte proliferation (Fig. 5D ). This result was confirmed by using the RCR252 blocking antibody. There are at least two possible explanations for this endogenous effect. Firstly, EPCR itself may stimulate proliferation. Secondly, PC may be produced and secreted by tenocytes which then binds to EPCR and stimulates cell growth. This is similar to the autocrine effect of PC recently described in keratinocytes [18] . Such a mechanism requires tenocytes to possess their own PC system which can not only synthesize PC, but also activate PC to APC and mediate the function of PC/APC by its receptors. Further studies are required to elucidate this mechanism.
The MAPK pathway is a prerequisite for growth factor stimulated mitogenesis in many cell types [36] . Three major downstream MAPK cascades are mitogen-activated ERK1/2 and stress/cytokine activated p38 and c-Jun N-terminal kinases, whereas p38 MAP kinase functions to promote differentiation and apoptosis [37] . Our data suggest that ERK2 is the major MAP kinase associated with APC enhancement of cell proliferation. In contrast, p38 exhibited opposite effects to ERK2. These results are in keeping with previous studies which present evidence that p38 MAP kinase functions to promote differentiation and apoptosis while signalling through ERK2 promotes keratinocyte proliferation and survival and endothelial cell proliferation [18, 25, 37] 
